Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Drugs - Real World Outcomes|June 30, 2022
Treatment Patterns During Major Depressive Episodes Among Patients with Major Depressive Disorder: A Retrospective Database AnalysisRakesh Jain, Sara Higa, Katelyn Keyloun, et al.Infectious Diseases and Therapy|November 13, 2019
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE TrialMatthew W McCarthy, Katelyn R Keyloun, Patrick Gillard, et al.Headache|June 11, 2014
Treatment persistence and switching in triptan users: a systematic literature reviewAndrew J Messali, Mo Yang, Patrick Gillard, et al.Journal of Global Antimicrobial Resistance|February 24, 2019
Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infectionsUrania Rappo, Pedro L Gonzalez, Sailaja Puttagunta, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 22, 2025
Long-Term Prophylactic Treatment Preferences and Willingness to Switch Therapy in Individuals With Hereditary AngioedemaCourtney Olson, Michael Lionetti, Christine Poulos, et al.Movement Disorders Clinical Practice|October 25, 2016
Impact of Cervical Dystonia on Work Productivity: An Analysis From a Patient RegistryEric S Molho, Mark Stacy, Patrick Gillard, et al.Journal of Medical Economics|October 6, 2023
Healthcare resource utilization and costs for patients with postoperative atrial fibrillation in the United StatesTae Jin Park, Ryan Hansen, Patrick Gillard, et al.International Journal of Stroke : Official Journal of the International Stroke Society|August 5, 2014
Evaluation of the Post Stroke Checklist: a pilot study in the United Kingdom and SingaporeAnthony B Ward, Christopher Chen, Bo Norrving, et al.Cephalalgia : an International Journal of Headache|November 13, 2016
Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysisZsolt Hepp, David W Dodick, Sepideh F Varon, et al.Journal of Managed Care & Specialty Pharmacy|September 30, 2023
Real-world persistence and costs among patients with chronic migraine treated with onabotulinumtoxinA or calcitonin gene-related peptide monoclonal antibodiesTodd J Schwedt, Jae Lee, Kerry Knievel, et al.Pageof 5